Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nightingale Health

0.97 EUR+1.25 %25.9, 11.17
4,790 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor views
Compare
+1.25 %
+7.05 %
+17.96 %
-26.70 %
-52.59 %
-58.19 %
-9.16 %
-75.77 %
-81.13 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
59.23M EUR
Turnover
58.89K EUR
P/E (adj.) (27e)
-3.95
EV/EBIT (adj.) (27e)
-2.17
P/B (27e)
1.61
EV/S (27e)
3.21
Dividend yield-% (27e)
-
Coverage
Recommendation
Accumulate
Target price
1.10 EUR
Updated
16.09.2026
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 17.09.2026

Latest extensive report

Released: 13.06.2025

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Inderes Nightingale Health ja Archipelago Health solmivat sopimuksen Nightingale... Nightingale Health Oyj | Lehdistötiedote | 23.09.2026 klo 09:52:00 EESTNightingale Health ja Archipelago Health ovat allekirjoittaneet sopimuksen Nightingale Health Checkin tuomisesta pienten... Deals...
9/23/2026, 6:57 AM
by Tuuukka
23
Here are Antti’s comments on Nightingale’s new deal Nightingale Health announced on Tuesday that it has agreed with Coronaria Kuntoutuspalvelut on the use of its Remote Health Check test as part of Coronaria’s new weight management service. The news is a continuation of several partnership...
9/22/2026, 5:22 AM
by Sijoittaja-alokas
15
Inderes Nightingale Healthin Remote Health Check osaksi Coronarian uutta... Nightingale Health Oyj | Lehdistötiedote | 22.09.2026 klo 07:20:00 EESTNightingale Health ja Coronaria Kuntoutuspalvelut ovat sopineet Nightingale Healthin Remote Health Checkin käytöstä Coronarian... If ...
9/22/2026, 4:24 AM
by Tuuukka
12
Here are Antti’s comments regarding the new deal Nightingale Health announced on Wednesday that it has signed a service agreement with Archipelago Health to bring its test to the British Crown Dependencies, Bermuda, and the Caribbean. The news is an expected follow-up step to the...
yesterday
by Sijoittaja-alokas
10
The Finnish state’s social and healthcare (SOTE) costs are approaching 30 billion and debt is being accumulated for 10+ years. I don’t believe that the current model, where an individual can ruin their health and the taxpayer pays the bill, will work for much longer anymore. In that...
9/17/2026, 11:30 AM
by Vichy
10
Social and healthcare expenditures will probably never drop to zero. But citizens could be penalized based on how risky their lifestyle is. For example, type 2 diabetes is almost entirely self-induced. It can also be put into remission with a high success rate. In Finland, society...
9/17/2026, 2:52 PM
by Vichy
6
Coronaria – 17 Sep 26 Nightingale-verianalyysi auttaa seuraamaan painonhallinnan vaikutuksia... Nightingale-verianalyysi on osa Coronarian Painonhallintapalvelua. Se auttaa seuraamaan veriarvoja, sairastumisriskejä ja elämäntapamuutosten vaikutuksia terveyteen.
9/22/2026, 5:05 AM
by Pertti
4
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5.11
2026

General meeting '26

9.3
2027

Interim report Q2'27

Agreement between Nightingale and Archipelago Health
Analyst Comment24.09.2026, 07.31 by
Antti Siltanen

Agreement between Nightingale and Archipelago Health

The service agreement opens a new distribution channel to the Caribbean and the British Crown Dependencies.

Nightingale Health
Press release23.09.2026, 08.52

Nightingale Health and Archipelago Health enter into agreement to bring the Nightingale Health Check to the Crown Dependencies, Bermuda and the Caribbean

Nightingale Health
Nightingale's tests to become part of Coronaria's weight management service
Analyst Comment22.09.2026, 08.15 by
Antti Siltanen

Nightingale's tests to become part of Coronaria's weight management service

Numerous small contracts support our growth forecasts.

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release22.09.2026, 06.20

Nightingale Health's Remote Health Check becomes part of Coronaria's new weight management service in Finland

Nightingale Health
Nightingale H2'26: The mission is clear – deals, deals, deals!
Research17.09.2026, 09.52 by
Antti Siltanen, Antti Luiro

Nightingale H2'26: The mission is clear – deals, deals, deals!

The company is investing fully in sales to achieve its growth targets.

Nightingale Health
Nightingale Health H2'26: Projects are progressing24:54
Video16.09.2026, 15.57 by
Antti Siltanen

Nightingale Health H2'26: Projects are progressing

During the second half of the financial year, Nightingale Health's revenue grew to 3.09 MEUR.

Nightingale Health
Nightingale Health 2025–2026 Results Webcast
Webcast16.09.2026, 13.00

Nightingale Health 2025–2026 Results Webcast

Nightingale Health
Regulatory press release16.09.2026, 08.00

Nightingale Health Plc Financial Statements Release 1 July 2025 – 30 June 2026

Nightingale Health
Nightingale to start Eloisa pilot in public healthcare
Analyst Comment15.09.2026, 07.19 by
Antti Siltanen

Nightingale to start Eloisa pilot in public healthcare

The Eloisa project opens the door towards public healthcare.

Nightingale Health
Press release14.09.2026, 15.56

Nightingale Health's disease risk detection becomes part of public primary healthcare in South Savo: registration for Eloisa's Wellbeing Gift opened today

Nightingale Health
Nightingale H2'26 preview: Growth driven by research projects and Terveystalo
Analyst Comment11.09.2026, 08.05 by
Antti Siltanen

Nightingale H2'26 preview: Growth driven by research projects and Terveystalo

We estimate that H2 revenue grew by 47%, driven by research projects and the Terveystalo partnership.

Nightingale Health
Nightingale expands to Croatia
Analyst Comment10.09.2026, 08.14 by
Antti Siltanen

Nightingale expands to Croatia

The commercial agreement was preceded by three completed pilots.

Nightingale Health
Press release09.09.2026, 09.30

Nightingale Health and Genom partner to bring blood-based risk detection to clinics and laboratories across Croatia

Nightingale Health
Regulatory press release19.08.2026, 08.00

Changes in Nightingale Health Plc's management team

Nightingale Health
Press release19.08.2026, 08.00

US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas

Nightingale Health
Analyst Comment19.08.2026, 09.12 by
Antti Siltanen

Nightingale's remote tests to be included in Supernormal's weight loss service

The Supernormal collaboration, with over 10,000 users, integrates remote testing into GLP-1 medication treatments.

Nightingale Health
Press release18.08.2026, 08.57

Nightingale Health and Supernormal partner to bring at-home blood testing to medical weight loss in Finland

Nightingale Health
New partnership for Nightingale in the UK
Analyst Comment18.08.2026, 09.18 by
Antti Siltanen

New partnership for Nightingale in the UK

The partnership paves the way in the UK private healthcare market.

Nightingale Health
Press release17.08.2026, 10.30

Nightingale Health and Personalised Health Clinics collaborate on preventive metabolic health in the UK

Nightingale Health
Press release01.07.2026, 15.00

Nightingale Health and Archipelago Health partner to bring preventive screening to small-island health systems in the Crown Dependencies, Bermuda and the Caribbean

Nightingale Health